Ozempic, Wegovy Users More Likely to Develop 'Stomach Paralysis.

*Research Highlights:*

- Studies have found a link between GLP-1 drugs, such as Ozempic and Wegovy, and an increased risk of developing gastroparesis, also known as 'stomach paralysis' ¹.

- Gastroparesis is a condition that slows down the emptying of the stomach, leading to symptoms like nausea, vomiting, bloating, and abdominal pain ².

- Experts emphasize that gastroparesis is a reversible and expected side effect of taking GLP-1 drugs, and the risk is still relatively low ¹.


*Study Findings:*

- A study published in the Journal of the American Medical Association found that users of Ozempic and Wegovy are more likely to develop severe stomach problems, including gastroparesis, pancreatitis, and bowel obstruction ³.

- Another study presented at Digestive Disease Week 2024 found that patients taking GLP-1 drugs were 66% more likely to be diagnosed with gastroparesis than those who were not ¹.


*Expert Insights:*

- Dr. Beverly Tchang, an endocrinologist, notes that while there is an increased risk, the percentages are still fairly low, and gastroparesis is a reversible condition ¹.

- Dr. Dan Azagury, a bariatric surgeon, emphasizes that gastroparesis is not worrisome and is an expected effect of taking GLP-1 drugs ¹.


*Conclusion:*

While Ozempic and Wegovy users may be at a higher risk of developing gastroparesis, it's essential to remember that the risk is still relatively low, and the condition is reversible. If you're taking these medications, it's crucial to discuss any concerns with your healthcare provider.